Connection
Elizabeth Kozora to Antiphospholipid Syndrome
This is a "connection" page, showing publications Elizabeth Kozora has written about Antiphospholipid Syndrome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.799 |
|
|
|
-
Kozora E, Erkan D, Zhang L, Zimmerman R, Ramon G, Ulug AM, Lockshin MD. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. Clin Exp Rheumatol. 2014 Jan-Feb; 32(1):34-40.
Score: 0.434
-
Yelnik CM, Kozora E, Appenzeller S. Cognitive disorders and antiphospholipid antibodies. Autoimmun Rev. 2016 Dec; 15(12):1193-1198.
Score: 0.134
-
Yelnik CM, Kozora E, Appenzeller S. Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome. Curr Rheumatol Rep. 2016 Feb; 18(2):11.
Score: 0.128
-
Erkan D, Vega J, Ram?n G, Kozora E, Lockshin MD. A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis Rheum. 2013 Feb; 65(2):464-71.
Score: 0.104